Article · 24 Jun 2026
Conference abstract
Lipid metabolites and coronary plaque vulnerability
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Metabolomics has been increasingly recognized as an enabling technique with the potential to identify key metabolomic features in an attempt to understand the pathophysiology and differentiate different stages of Coronary Heart Disease (CHD). We performed comprehensive metabolomic analysis in human plasma from 28 human subjects with Stable Angina (SA), Myocardial Infarction (MI), and Healthy Control (HC). Subsequent analysis demonstrated a uniquely altered metabolic profile in these CHD: a total of 18, 37 and 36 differential metabolites were identified to distinguish SA from HC, MI from SA, and MI from HC groups respectively. Among these metabolites, glycerophospholipid (GPL) metabolism emerged as the most significantly disturbed pathway. We used a targeted metabolomic approach to systematically analyse GPL, oxidized phospholipid (oxPL), and downstream metabolites derived from polyunsaturated fatty acids (PUFAs), such as arachidonic acid and linoleic acid. Surprisingly, lipids associated with lipid peroxidation (LPO) pathways including oxidized PL and isoprostanes, isomers of prostaglandins, were significantly elevated in plasma of MI patients comparing to HC and SA, consistent with the notion that oxidative stress-induced LPO is a prominent feature in CHD. Optical coherence tomography (OCT) has been considered as the ideal tool for the evaluation of atherosclerotic plaques. Circulating trimethylamine-N-oxide (TMAO), which is a metabolite of the dietary lipid phosphatidylcholine by gut microbiota, has recently been linked to elevated CHD risk. A total of 26 patients with CAD were recruited to assess coronary plaque using OCT and measure plasma TMAO level. According to plaque rupture status, patients were divided into plaque rupture group (n=12) and non-plaque rupture group (n=14). Plasma TMAO level was significantly higher in patients with plaque rupture than in those with non-plaque rupture (8.6±4.8 μmol/L vs. 4.2±2.4 μmol/L, p=0.011). In conclusion, circulating TMAO level may reflect coronary plaque vulnerability and progression.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Interventional Cardiology Journal.
Article · 24 Jun 2026
Valve Calcification: Causes, Clinical Manifestations, Diagnosis, and Current Management
Article · 24 Jun 2026
Aortic Regurgitation: Causes, Clinical Features, Diagnosis, and Treatment Options
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology Journal
- SubjectCardiology
- BylineArticles whose byline prints “Lemin Zheng”
- BylineArticles whose byline prints “Mingming Zhao”
- BylineArticles whose byline prints “Huiyong Yin”